PCH
Polar Capital Holdings’s Y-mAbs Therapeutics YMAB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.07M | Sell |
1,789,800
-41,200
| -2% | -$186K | 0.04% | 208 |
|
|
2025
Q1 | $8.11M | Hold |
1,831,000
| – | – | 0.05% | 203 |
|
|
2024
Q4 | $14.3M | Hold |
1,831,000
| – | – | 0.08% | 170 |
|
|
2024
Q3 | $24.1M | Hold |
1,831,000
| – | – | 0.11% | 129 |
|
|
2024
Q2 | $22.1M | Hold |
1,831,000
| – | – | 0.13% | 124 |
|
|
2024
Q1 | $29.8M | Sell |
1,831,000
-225,872
| -11% | -$3.67M | 0.16% | 118 |
|
|
2023
Q4 | $14M | Sell |
2,056,872
-46,426
| -2% | -$317K | 0.09% | 159 |
|
|
2023
Q3 | $11.5M | Hold |
2,103,298
| – | – | 0.08% | 175 |
|
|
2023
Q2 | $14.3M | Buy |
2,103,298
+111,369
| +6% | +$756K | 0.07% | 170 |
|
|
2023
Q1 | $9.98M | Hold |
1,991,929
| – | – | 0.06% | 187 |
|
|
2022
Q4 | $9.72M | Sell |
1,991,929
-539,617
| -21% | -$2.63M | 0.08% | 194 |
|
|
2022
Q3 | $36.5K | Sell |
2,531,546
-421,125
| -14% | -$6.07K | 0.23% | 95 |
|
|
2022
Q2 | $44.7K | Buy |
2,952,671
+75,000
| +3% | +$1.14K | 0.26% | 84 |
|
|
2022
Q1 | $34.2K | Buy |
2,877,671
+1,500,000
| +109% | +$17.8K | 0.15% | 118 |
|
|
2021
Q4 | $22.3K | Buy |
1,377,671
+222,710
| +19% | +$3.61K | 0.08% | 159 |
|
|
2021
Q3 | $33K | Buy |
1,154,961
+569,040
| +97% | +$16.2K | 0.13% | 130 |
|
|
2021
Q2 | $19.8K | Buy |
585,921
+577,892
| +7,198% | +$19.5K | 0.09% | 168 |
|
|
2021
Q1 | $243K | Sell |
8,029
-499,604
| -98% | -$15.1M | ﹤0.01% | 315 |
|
|
2020
Q4 | $25.1M | Buy |
+507,633
| New | +$25.1M | 0.15% | 131 |
|